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Naive CD4 T-cell maintenance is critical for immune competence. We investigated here 
the fine-tuning of homeostatic mechanisms of the naive compartment to counteract the 
loss of de novo CD4 T-cell generation. Adults thymectomized in early childhood during 
corrective cardiac surgery were grouped based on presence or absence of thymopoiesis 
and compared with age-matched controls. We found that the preservation of the CD31− 
subset was independent of the thymus and that its size is tightly controlled by peripheral 
mechanisms, including prolonged cell survival as attested by Bcl-2 levels. Conversely, a 
significant contraction of the CD31+ naive subset was observed in the absence of thymic 
activity. This was associated with impaired responses of purified naive CD4 T-cells to 
IL-7, namely, in  vitro proliferation and upregulation of CD31 expression, which likely 
potentiated the decline in recent thymic emigrants. Additionally, we found no apparent 
constraint in the differentiation of naive cells into the memory compartment in individuals 
completely lacking thymic activity despite upregulation of DUSP6, a phosphatase 
associated with increased TCR threshold. Of note, thymectomized individuals featuring 
some degree of thymopoiesis were able to preserve the size and diversity of the naive 
CD4 compartment, further arguing against complete thymectomy in infancy. Overall, our 
data suggest that robust peripheral mechanisms ensure the homeostasis of CD31− naive 
CD4 pool and point to the requirement of continuous thymic activity to the maintenance 
of IL-7-driven homeostatic proliferation of CD31+ naive CD4 T-cells, which is essential to 
secure T-cell diversity throughout life.
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inTrODUcTiOn
Long-term preservation of the naive CD4 T-cell pool is vital to ensure immunity to foreign antigens 
and to maintain peripheral tolerance (1, 2). Naive CD4 T-cells are preserved throughout life due 
to a dynamic balance between thymic generation, and peripheral proliferation, survival, death, or 
differentiation into memory/effector cells (1, 3).
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The thymus is known to be functional up to the sixth decade 
of life, even though an age-dependent decline in thymic activity 
occurs (4). Thymic output can be estimated through the quantifi-
cation of TCR rearrangement circles (TRECs), which are excision 
by-products generated during T-cell development in the thymus 
(4). These episomal DNA fragments are progressively diluted 
with cell division in the periphery (5), being thus enriched in 
recent thymic emigrant cells (RTEs). Aging is associated with a 
progressive reduction in TREC levels (4). This decline is much 
more striking than the one observed in naive CD4 T-cell counts, 
indicating that the loss of cell replenishment due to thymic invo-
lution is complemented by peripheral dilution due to cell prolif-
eration (4, 6–8). In fact, in contrast to mice, the establishment 
and maintenance of the human naive CD4 T-cell compartment 
are currently thought to significantly rely on post-thymic T-cell 
proliferation (3, 9, 10). Several in silico studies suggest that thymic 
output per se is insufficient to guarantee the size of the periph-
eral naive T-cell compartment without a major contribution of 
cell proliferation in the periphery (3, 9, 10). This homeostatic 
proliferation is driven by self-peptide/MHC interaction and/or 
cytokines, namely, IL-7 (9, 11, 12).
IL-7 is essential for thymopoiesis and plays a key role in periph-
eral naive T-cell survival through the induction of Bcl-2 (11, 13). 
In addition, IL-7 induces low-level naive T-cell proliferation (11, 
13), which is particularly important in lymphopenic clinical 
settings (11, 13). In steady-state conditions, this homeostatic 
proliferation within the naive CD4 T-cell compartment is mainly 
restricted to the subset expressing CD31 [platelet endothelial cell 
adhesion molecule (PECAM-1)] (14), a population that includes 
the RTEs and is thought to have a broadly diverse TCR repertoire 
(12). We have also shown that IL-7 increases the levels of expres-
sion of CD31 in this subset (14). The biological significance of 
CD31 expression is still debatable, though it has been suggested 
that it may limit TCR-mediated naive CD4 T-cell responses 
through inhibitory signaling ascribed to its cytoplasmic immune-
receptor tyrosine-base inhibitory motifs (15). In agreement, the 
homeostatic proliferation of CD31− naive CD4 T-cells is thought 
to be mainly mediated by low-affinity self-peptide/MHC interac-
tions (16). Of note, CD31 expression is lost after TCR stimulation 
of naive CD4 T-cells (2, 17–19).
There are few studies on human naive CD4 T-cell homeostasis, 
and the interplay between peripheral mechanisms and the age-
associated decline in thymic output remains unclear (3, 9, 10). 
Adults thymectomized early in infancy due to corrective cardiac 
surgery provide a unique setting to address this issue (20–27). 
Using this clinical model, we show here that thymic activity is 
required to ensure IL-7-mediated peripheral homeostatic prolif-
eration, whereas the homeostasis of the CD31− compartment is 
preserved in the absence of thymic activity.
MaTerials anD MeThODs
study Design
Blood was collected from 22 adult patients submitted to thymec-
tomy during corrective cardiac surgery in early childhood and 
20 age-matched healthy controls. All the subjects gave written 
informed consent for blood sampling and processing. The study 
was approved by the Ethical Boards of Faculdade de Medicina 
da Universidade de Lisboa, Centro Hospitalar Lisboa Norte, and 
Hospital de Santa Cruz, Portugal.
cell isolation and cell culture
Peripheral blood mononuclear cells (PBMCs) were isolated from 
freshly collected heparinized blood via Ficoll-Paque PLUS (GE 
Healthcare, Uppsala, Sweden). Naive CD4 T-cells were subse-
quently purified by negative selection (purity > 96%, StemCell 
Technologies, Grenoble, France). Purified naive CD4 T-cells 
were cultured at 1 × 106 cells/ml with either IL-7 (10 ng/ml; R&D 
Systems, Minneapolis, MN, USA) or IL-2 (20 IU/ml; NIH/AIDS 
Research and Reference Program, Division of AIDS, NIAID, 
Hoffman-La Roche), for up to 13 days (d), with media replace-
ment at d3 and d7, as we have previously described (14, 28).
Flow cytometry
Ex vivo phenotypic analysis was performed in freshly collected 
whole blood using an eight-color staining protocol and a panel 
of monoclonal antibodies previously described (28). Purified 
naive CD4 T-cells were surface stained ex vivo and upon culture, 
followed by intracellular staining using eBioscience FoxP3 
kit (eBioscience, San Diego, CA, USA), as described (28). At 
least 150,000 events were acquired for each sample on a BD 
LSRFortessa (BD Biosciences, San Jose, CA, USA). Data were 
analyzed using FlowJo software (TreeStar, Ashland, OR, USA) 
after doublet exclusion. Results are presented as proportion of a 
cell population or as mean fluorescence intensity (MFI) of a given 
marker within the specified population.
Tcr activation
Purified untouched naive CD4 T-cells were cultured at 
1 × 106 cells/ml (25,000 cells/well) and stimulated with increas-
ing concentrations of beads coated with anti-CD3 and anti-CD28 
monoclonal antibodies (Dynabeads, Thermo Fischer Scientific), 
in order to generate a dose–response curve of TCR stimulation at 
the single-cell level. In agreement with a previously reported pro-
tocol (29), antibody against CD40L (clone 89-76, BD Bioscience) 
was added to the culture media to improve the staining. After 
6 h, cells were collected and surface stained, as described (28), for 
the marker of cell differentiation (CD45RO) and the additional 
activation marker (CD69).
Trec Quantification
Signal joint (sj) and DβJβTREC analyses were conducted as 
described (5, 30). Briefly, multiplex PCR amplification for sjTREC, 
DJβ1TRECs (Dβ1-Jβ1.1 to 1.6), or DJβ2TRECs (Dβ2-Jβ2.1 to 
2.7), together with the CD3γ chain was performed in triplicate 
on lysed PBMC. TREC and CD3γ quantifications were then 
performed using a LightCycler™ in independent experiments, 
with the same first-round serial dilution standard curve. This 
highly sensitive nested quantitative PCR assay allowed detection 
of 1 copy in 105 cells for any excision circle. The sj/βTREC ratio 
[sjTREC/105 cells/(DJβ1TRECs/105 cells  +  DJβ2TRECs/105 
cells)] was calculated as described (30).
TaBle 1 | clinical–epidemiological characteristics of cohorts.
healthy Thya ØThya
Number (male/female) 20 (8/12) 14 (6/8) 8 (5/3)
Age, years 22 [18–29] 25 [18–30] 23 [20–27]
Age at thymectomy, months NA 8 [1–60] 21 [12–72]
Total lymphocytes/μl 2,408 [1,430–3,502] 2,219 [1,230–3,400] 2,005 [934–2,618]*
% T-cells (CD3+) 72.7 [50.2–79.0] 70.5 [57.3–82.7] 66.6 [42.7–71.2]*,#
% CD4 T-cells 39.9 [31.2–60.0] 41.0 [33.8–55.3] 42.7 [20.20–46.4]
Serum IL-7b, pg/ml 15.0 [6.5–23.3] 12.8 [5.3–16.2]* 14.8 [8.3–19.8]
NA indicates not applicable. Results are shown as median and range in brackets.
*P-value <0.05 in comparison with healthy.
#P-value <0.05 in comparison with Thy.
aThymectomy was performed during reconstructive cardiac surgery to facilitate surgical access to the heart and great vessels; patients with syndromatic cardiopathy were excluded 
(e.g., trisomy 21, velocardiofacial syndrome, or DiGeorge syndrome); individuals were not treated with drugs known to influence the immune system; ØThy, no thymic activity based 
on surgical reports of complete thymus removal and levels of sjTRECs clearly below the lower level found in controls; Thy, some degree of thymic activity attested by sjTREC levels 
within the range of age-matched controls; none of the individuals featured increased rate of infections or autoimmune manifestation.
bSerum IL-7 levels were quantified using Human IL-7 Quantikine HS ELISA kit (R&D Systems).
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mrna Quantification
Total RNA was extracted from purified naive CD4 T-cells 
using Quick-RNA MicroPrep (Zymo Research Corporation, 
Irvine, CA, USA). cDNA was synthesized from 50  ng of 
RNA (SuperScript III Reverse Transcriptase, Thermo Fischer 
Scientific) and used to quantify the expression levels of 
KLF2, FOXP1, P21, BIM, DUSP4, and DUSP6 in duplicates, 
using TaqMan Gene Expression Assays on a ViiA7 Sequence 
Detection system (both from Thermo Fischer Scientific). Results 
are expressed as ΔCT normalized to the medium CT levels of 
GAPDH and HPRT.
Tcr spectratyping analysis
Total RNA was extracted from 105 to 106 cells with RNeasy kit 
(Qiagen, MD, USA), and first-strand cDNA synthesized from 1 
to 2 µg of RNA (SuperScript III) using an equivolume mixture of 
random hexamers and oligo (dT). Amplification of the TCRVβ 
CDR3 was performed using primers specific for each TRBV 
family and a common TRCB reverse primer (31), followed by a 
run-off reaction that extends each different PCR product with a 
second TRCB FAM-labeled primer; and the third step, in which 
each different fluorescent TRBV-TRBC PCR fragment was sepa-
rated using a capillary electrophoresis-based DNA automated 
sequencer. Data were collected and analyzed with GeneMapper 
v4.0 (Thermo Fischer Scientific) for size and fluorescence inten-
sity determination.
statistical analysis
Statistical analysis was performed with Graph Prism Version 
5.01 (GraphPad Software, San Diego, CA, USA). The following 
tests were used for analyzing epidemiological data and results 
from ex vivo studies as appropriate: Wilcoxon-Signed Rank/
paired T-test for pairwise comparisons and unpaired T-test/
Mann–Whitney for unpaired comparisons, for Gaussian and 
non-Gaussian distribution respectively. Cultures were analyzed 
using one-way ANOVA. Results were expressed as median 
(interquartile range or range when n < 4). P values <0.05 were 
considered significant.
resUlTs
evidence of Thymus activity in adults 
Thymectomized during the First Year 
of life
We studied a cohort of 22 adults submitted to thymectomy in 
early childhood during corrective cardiac surgery and 20 age-
matched healthy controls (Table 1; Table S1 in Supplementary 
Material). Of note, the thymic function is relatively stable in 
healthy individuals during the age-period spanned (4). The 
thymectomized patients were stratified into two groups accord-
ing to evidence of residual thymic activity (Table 1; Table S1 in 
Supplementary Material). No thymic activity (∅Thy) strictly 
refers to cases with surgical reports of complete thymus removal 
and levels of sjTRECs clearly below the lower level found in 
controls (P < 0.0001, Figure 1A), as we previously reported (28). 
Individuals with some degree of thymic activity (Thy) featured 
sjTREC levels within the range of age-matched controls, though 
significantly lower (P = 0.0061, Figure 1A).
Interestingly, these two groups showed almost no overlap 
between age at thymectomy, which was performed during the 
first year of life in all Thy cases except two and later on in all 
∅Thy patients (Table S1 in Supplementary Material). A previous 
study also found an association between preservation of thymic 
activity and younger age at thymectomy, which was attributed 
to loss of thymus regenerative capacity in children older than 
18 months (24, 32). It is also noteworthy that complete thymic 
tissue removal is more likely to occur after the first year of life 
due to the surgical procedures required for the type of cardiac 
defects (Table S1 in Supplementary Material), as well as due to 
age-related anatomic specificities (21) Of note, individuals with 
syndromatic cardiac defects were not included (Table S1 in 
Supplementary Material).
In agreement with complete lack of thymic activity, the ∅Thy 
group featured decreases in naive CD4 T-cell frequency and 
absolute numbers, which were statistically significant not only in 
comparison with healthy individuals (P = 0.0012 and P = 0.0006, 
respectively, Figure  1B) but also with Thy (P  =  0.0041 and 
FigUre 1 | naive cD4 T-cell compartment in adults thymectomized early in life. (a) Quantification of sjTREC levels in peripheral blood mononuclear cells 
(PBMCs) from thymectomized patients without (∅Thy), or with evidence of thymic activity (Thy), and in age-matched healthy individuals. (B) Contour plots illustrating 
CD45RO and CCR7 analysis within circulating CD4 T-cells of representative individuals from the three cohorts; graphs show naive CD4 T-cell frequency (top) and 
counts (bottom). (c) sj/βTREC ratio quantified in PBMCs from Thy and healthy individuals. Each dot represents one individual, bars represent median, and P values 
are shown.
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P = 0.0019, respectively, Figure 1B). These cells featured a truly 
naive phenotype based on an extensive panel of naive markers 
and lack of expression of molecules associated with a memory 
phenotype, as we have previously reported (28).
On the other hand, Thy patients showed no reduction in lym-
phocyte counts (Table 1) and maintained the naive CD4 T-cell 
compartment (Figure  1B). In order to estimate their effective 
thymic output, we quantified the sj/βTREC ratio, which reflects 
the number of proliferation cycles undergone by precursor T-cells 
during their intra-thymic differentiation and directly correlates 
with thymic activity (30). We observed similar levels of sj/βTREC 
ratio in Thy and age-matched healthy individuals (Figure 1C). 
Together with close to normal sjTREC contents, this observation 
supports a major contribution of thymic recovery to the mainte-
nance of the size of naive CD4 T-cell compartment upon partial 
thymectomy.
We further assessed the impact of the degree of thymectomy 
on the structural diversity of naive CD4 T-cells by spectratyping 
analysis of their TCR repertoire. The distribution of the CDR3 
lengths within each different Vβ family is considered to reflect the 
overall sequence diversity (33). A diverse polyclonal TCR reper-
toire is associated with a Gaussian distribution of CDR3 lengths, 
whereas skewed TCR repertoires feature a reduced number of 
peaks. A relatively preserved TCR diversity was observed in Thy 
patients as compared to age-matched controls (P  =  0.2620), 
supporting that their degree of thymic activity was sufficient to 
ensure the preservation of the quality of the naive CD4 T-cell 
compartment (Figures 2A,B). Patients with no thymic activity 
exhibited higher numbers of non-polyclonal Gaussian families 
than both Thy (P < 0.0001) and healthy individuals (P = 0.0001), 
as shown in Figure 2.
Of note, these differences between the two thymectomized 
cohorts could not be attributed to a distinct prevalence of CMV 
infection, since a similar proportion of individuals with IgG sero-
positivity against CMV was observed in ∅Thy and Thy cohorts 
(Table S1 in Supplementary Material). Moreover, the contrac-
tion of the naive CD4 T-cell compartment in ∅Thy individuals 
was not restricted to those seropositive for CMV, as previously 
reported (21).
Overall, peripheral homeostatic mechanisms were unable 
to prevent the contraction of the naive CD4 T-cell compart-
ment upon complete thymus removal in infancy, whereas 
the maintenance of some degree of thymic activity allowed 
preservation of naive CD4 T-cells with a diverse TCR repertoire 
into adulthood.
lack of Thymic activity Does not 
associate with increased Threshold 
for Tcr activation of naive cD4 T-cells
The maintenance of naive T-cells is also determined by the rate 
of their differentiation into memory–effector cells. Of note, both 
FigUre 2 | spectratyping analysis of naive cD4 T-cell diversity in adults thymectomized early in life. CD3 length distribution within each of the 22 Vβ 
families of purified naive CD4 T-cells analyzed by spectratyping: (a) illustrative examples from thymectomized patients without (right, ∅Thy1 in Table S1 in 
Supplementary Material) and with evidence of thymic activity (middle, Thy6 in Table S1 in Supplementary Material), as well as age-matched healthy (left) individuals; 
(B) proportion of the illustrated patterns within each Vβ family in the three cohorts (∅Thy, bottom, n = 7; Thy, middle, n = 6; healthy, top, n = 12).
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central and effector memory CD4 T-cell counts in individuals 
lacking thymic activity were found to be similar to those in age-
matched healthy controls (Figure  3A). Therefore, we assessed 
the expression of a panel of genes known to be involved in 
the regulation of cell quiescence and/or of the threshold for 
TCR-mediated cell activation in purified naive CD4 T-cells 
from thymectomized and healthy individuals (Figure 3B). No 
alterations were found in the expression levels of the following 
genes: Krüppel-like factor 2 (KLF-2) (34), the transcription 
factor FOXP1 (35), CDKN1A (encoding the cyclin-dependent 
kinase inhibitor p21cip1/waf) (36), the proapoptotic Bcl-2 family 
member BIM (37), and the dual-specificity protein phosphatase 
DUSP4 (38). However, individuals with no thymic activity fea-
tured significantly higher DUSP6 transcript levels than controls, 
an increase not observed in those with some preservation of 
thymopoiesis (Figure 3B).
DUSP6 is highly specific for ERKs, leading to reduction of 
ERK activity that is critical for efficient TCR signaling (38, 39). 
Therefore, high DUSP6 levels might be associated with an increase 
in the threshold for TCR-induced activation in ∅Thy. To test this 
possibility, we performed a dose–response TCR stimulation of 
purified naive CD4 T-cells and quantified the upregulation of the 
early activation markers CD40L and CD69, in parallel with the 
downregulation of CD3 expression and induction of the memory 
marker CD45RO. Contrarily to our expectation, individuals 
completely lacking thymic activity responded to TCR stimulation 
as efficiently as healthy subjects (Figure 3C).
In conclusion, we found no apparent constraint in the dif-
ferentiation of naive CD4 T-cells into the memory compartment 
in individuals completely lacking thymic activity.
Preservation of the cD31− compartment 
of cD4 naive T-cells in the absence of 
Thymic activity
The CD31 molecule has been shown to be expressed in all RTEs 
and to be lost upon TCR stimulation of naive CD4 T-cells (12, 18). 
Next, we investigated the contribution of peripheral cell survival 
and cell cycling to the homeostasis of the CD31+ and CD31− naive 
CD4 T-cell subsets according to the degree of thymic activity.
The CD31+ compartment was preserved in Thy patients 
(Figures 4A,B). Conversely, it was significantly contracted in the 
∅Thy cohort, both in frequency (Figure 4A) and absolute counts 
(Figure 4B), as expected in the absence of thymic activity (3, 20). 
Of note, the median level of CD31 expression within CD31+ naive 
CD4 T-cells was not significantly different in thymectomized 
individuals (CD31 MFI: healthy 4,494 [3,490–4,872]; Thy 3,573 
[3,255–4,453]; ØThy 3,936 [2,658–4,170]; P > 0.05).
Importantly, despite the marked naive CD4 T-cell lympho-
penia, ∅Thy featured preserved CD31− naive CD4 T-cell counts 
FigUre 3 | Maintenance of naive cD4 T-cell quiescence upon thymectomy. (a) Absolute numbers of circulating central memory (CD45RO+CCR7+) and 
effector memory (CD45RO+CCR7−) cells in thymectomized patients without (∅Thy) and with evidence of thymic activity (Thy), as well as age-matched healthy 
individuals; numbers below the graph indicate the number of individuals. (B) mRNA expression levels of genes involved in cell cycle or maintenance of naive 
phenotype quantified in purified naive CD4 T-cells from the three cohorts; ΔCT normalized to the medium CT levels of GAPDH and HPRT are shown; numbers 
below the graph indicate the total number of samples tested and those with levels above the detection threshold of the respective gene. (c) Purified naive CD4 
T-cells from ∅Thy and healthy individuals were stimulated (6 h) with increasing concentrations of beads coated with anti-CD3 and anti-CD28 monoclonal antibodies 
with dot plots illustrating the upregulation of the activation markers CD40L and CD69 in one ∅Thy subject, and graphs showing frequencies of CD69+CD40L− cells 
(left), CD69+CD40L+ cells (middle), and CD3 mean fluorescence intensity (right); each dot represents one individual; lines connect means; and the two cohorts were 
compared with two-way ANOVA. Bars represent median and interquartile range. P values <0.05 are shown.
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(Figure 4B). This finding adds to previous data on aged individu-
als reporting preservation of the CD31− compartment in parallel 
with the progressive decline of CD31+ cell counts (40) and argues 
in favor of the robustness of the homeostasis of CD31− naive CD4 
T-cells in individuals lacking thymic activity.
The expression levels of the survival marker Bcl-2 were 
upregulated in both thymectomized cohorts as compared to 
healthy controls (∅Thy: P = 0.0187; Thy: P = 0.0487; Figure 4C), 
suggesting increased naive CD4 T-cell survival irrespectively of 
the presence of thymic activity, which persisted for more than 
20 years post-thymectomy (Table 1). This increase was observed 
in both CD31+ and CD31− naive T-cells (Figure 4D). Of note, we 
found that the CD31− compartment featured significantly higher 
Bcl-2 MFI than CD31+ cells both in healthy and Thy individuals, 
a difference that was attenuated in ∅Thy (Figure 4D).
Regarding proliferation, a significant increase in the frequency 
of cycling cells within total naive CD4 T-cells was found only in 
∅Thy (P < 0.0001 to healthy, P = 0.0007 to Thy; Figure 4E). The 
proportion of Ki-67+ cells was significantly higher in the CD31− 
than in the CD31+ compartment in both healthy individuals and 
in Thy patients (Figure 4F). Nevertheless, its relative contribution 
to the pool of proliferating naive CD4 T-cells is minor (<1%), 
given the large overrepresentation of CD31+ cells in these 
individuals (Figure 4A). On the other hand, ∅Thy individuals 
featured an increase in the relative representation of the CD31− 
subset, associated with the loss of CD31+ cells (Figure 4A), in 
parallel with a significant increase in the frequency of cycling cells 
irrespective of CD31 expression (CD31− subset: P <  0.0001 to 
healthy; P = 0.0048 to Thy; CD31+ subset: P < 0.0001 to healthy; 
P < 0.0001 to Thy; Figure 4F).
Thus, we showed that the CD31− naive CD4 T-cell com-
partment was maintained in the absence of thymic output, in 
association with both expanded cell survival and increased 
proliferation.
FigUre 4 | homeostasis of the cD31+ and cD31− subsets of naive cD4 T-cells upon thymectomy. (a) Frequency of CD31+ cells within naive CD4 T-cells in 
thymectomized patients without (∅Thy) and with evidence of thymic activity (Thy), as well as age-matched healthy individuals. (B) Absolute numbers of CD31+ and 
CD31− naive CD4 T-cells in ∅Thy (n = 8), Thy (n = 14), and healthy (n = 19) individuals. (c) Bcl-2 mean fluorescence intensity (MFI) within naive CD4 T-cells. (D) Bcl-2 
MFI within the CD31+ and CD31− subsets in ∅Thy (n = 5), Thy (n = 9), and healthy (n = 17) individuals, as illustrated in the representative overlay histograms 
(numbers indicate Bcl-2 MFI). (e,F) Frequency of cycling cells (Ki-67+) within naive CD4 T-cells (e) and within the CD31+ and CD31− subsets (F) in the three cohorts. 
In scatter graphs, each dot represents one individual, and bars represent median; bar graphs show median and interquartile range. P values are shown.
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naive cD4 T-cells Feature reduced 
Proliferative response to il-7 In Vitro 
in the absence of Thymic activity In Vivo
Cytokine-driven homeostatic mechanisms are crucial for naive 
CD4 T-cell maintenance, and IL-7 is considered the key cytokine 
in these processes (13). Therefore, we hypothesized that naive CD4 
T-cells adjust their intrinsic ability to respond to IL-7 in order to 
counteract the decline in thymic output. Thus, we investigated the 
impact of IL-7 on purified naive CD4 T-cells, using a 13d culture 
system previously optimized in our laboratory (14, 28). We were 
able to purify the required amount of naive CD4 T-cells from 5 
ØThy and 11 Thy individuals, which were compared with samples 
from 14 healthy subjects. We found comparable ex vivo levels of 
IL-7Rα-chain (CD127) expression within naive CD4 T-cells in 
healthy and ∅Thy, and significantly higher levels in Thy individu-
als (Figure 5A). Others have shown that the proximal signaling 
through the IL-7 receptor is preserved in adults thymectomized 
FigUre 5 | impact of thymectomy on naive cD4 T-cell ability to respond to il-7. Purified naive CD4 T-cells from thymectomized individuals without (∅Thy) or 
with evidence of thymic activity (Thy), and age-matched healthy controls were cultured for 13d with IL-7 or IL-2. (a) Illustrative contour plots from one individual of 
each cohort showing maintenance of naive phenotype (CD45RA+) and downregulation of IL-7Rα (CD127) upon culture with IL-7 but not with IL-2; graph shows 
CD127 mean fluorescence intensity (MFI) within the CD31+ and CD31− compartments ex vivo (d∅) and upon culture with IL-2 or IL-7 in the three cohorts: CD127 
downregulation in response to IL-7 was statistically significant as compared to both d∅ and IL-2 in all cohorts/subsets (P < 0.001); no significant differences were 
found between d∅ and IL-2, except for CD31+ cells in healthy (P < 0.05); the comparison between cohorts revealed no significant differences, except for the levels 
of CD127 MFI at d∅ in Thy in comparison to both healthy (CD31+: P < 0.01; CD31−: P < 0.001) and ∅Thy (CD31+: P < 0.01) individuals. (B) Fold change of Bcl-2 
MFI within CD31+ and CD31− naive CD4 T-cells upon culture with IL-7 or IL-2 as compared to d∅ in the three cohorts: Bcl-2 upregulation with IL-7 was significant in 
all cohorts/subsets (P < 0.001) without inter-cohort differences, except for CD31+ naive CD4 T-cells in ∅Thy in comparison with healthy (P < 0.05); overlay 
histograms illustrate Bcl-2 expression within gated CD31+ and CD31− naive CD4 T-cells in d∅ and upon culture with IL-7 or IL-2 in a ∅Thy and an healthy individual. 
Each dot represents one individual, and bars represent median.
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in infancy, as assessed by STAT5 phosphorylation upon short-
term stimulation with IL-7 (20).
As illustrated in Figure 5A, the cells preserved their naive phe-
notype upon culture with either IL-7 or IL-2, including those from 
∅Thy individuals. The expected IL-7-mediated downregulation 
of CD127 expression (14, 41) was comparable in all individuals 
and, therefore, independent of the degree of thymic activity 
(Figure 5A). Of note, no changes occurred in the control culture 
condition with IL-2 (Figure 5A). Additionally, the upregulation 
of CD25 and CD95 by IL-7 (14, 42) was also similar in all cohorts, 
both in the CD31+ and CD31− compartments (data not shown).
An important physiological role of IL-7 relies on Bcl-2 induc-
tion (43). We found a clear upregulation of Bcl-2 expression, in 
both CD31+ and CD31− subsets in cultures with IL-7 in both 
thymectomized cohorts, which was not observed with IL-2 
(Figure 5B).
We then investigated the proliferative response of naive 
CD4 T-cells using the cell-cycling marker Ki-67, which we have 
shown to be the best approach to reveal low-level IL-7-driven 
proliferation (14). Unexpectedly, we found that in contrast to 
healthy and Thy cohorts, ∅Thy featured no significant increase 
in the frequency of cycling cells in response to IL-7, as com-
pared to both ex vivo and cultures with IL-2 (Figure  6A). As 
shown in Figure  6B, naive CD4 T-cell recovery per well was 
significantly higher upon culture with IL-7 than IL-2 in healthy 
(fold change 1.07 [0.86–1.54] versus 0.79 [0.51–1.63]; P = 0.0137) 
and Thy (fold change 1.15 [0.16–1.55] versus 0.65 [0.06–1.32]; 
P = 0.0259), but not in ∅Thy (fold change 0.87 [0.65–1.77] versus 
0.54 [0.34–1.66]; P = 0.2234). The cell recovery upon culture with 
IL-7 was significantly lower in ∅Thy as compared to healthy 
individuals (P = 0.0236).
We have previously shown that the IL-7-induced proliferation 
was restricted to the CD31+ subset in healthy subjects (14), which 
was confirmed here (Figures 6C,D). Notably, a similar profile was 
observed in Thy individuals (Figures 6C,D). By contrast, patients 
lacking thymic activity featured reduced proliferation upon IL-7 
stimulation (Figures 6C,D) and showed no significant increase in 
the frequency of cycling cells (Ki-67+) within the CD31+, as com-
pared to the CD31− subset (Figures 6C,D). As a consequence, 
the proportion of CD31+ within cycling cells was significantly 
lower in ∅Thy, as compared to both healthy and Thy individuals 
(P < 0.0001 and P = 0.007, respectively).
We have also previously shown that IL-7 upregulates the levels 
of expression of CD31 within the CD31+ naive CD4 T-cell subset 
in a PI3K-dependent manner (14, 28). Of note, the ∅Thy cohort 
reached significantly lower levels of upregulation of CD31 MFI 
within the CD31+ subset in response to IL-7, as compared to 
healthy (P = 0.0035), despite featuring comparable ex vivo levels 
FigUre 6 | impact of thymectomy on naive cD4 T-cell ability to proliferate in vitro in response to il-7. Purified naive CD4 T-cells from thymectomized 
patients without (∅Thy) or with evidence of thymic activity (Thy), and from age-matched healthy controls were cultured for 13d with IL-7 or IL-2. (a) Frequency of 
cycling cells (Ki-67+) within total naive CD4 T-cells ex vivo (d∅) and upon culture with IL-7 or IL-2. (B) Cell recovery counts upon culture with IL-7 or IL-2. (c) Contour 
plots illustrate the analysis of Ki-67 versus CD31 in representative ∅Thy, Thy, and healthy individuals. (D) Frequency of Ki-67+ cells within CD31+ and CD31− naive 
CD4 T cells. (e) CD31 expression (mean fluorescence intensity) within the CD31+ compartment at d∅ and upon culture with IL-7 or IL-2 in ∅Thy (n = 5), Thy (n = 7), 
and healthy (n = 14) individuals. Each dot represents one individual, and bars represent median and interquartile range. Significant P values are shown: *P < 0.05, 
**P < 0.01, and ***P < 0.001 for comparisons between conditions within each cohort; #P < 0.05 for comparisons between healthy and ∅Thy or Thy; §P < 0.05 for 
comparisons between ∅Thy and Thy.
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(P = 0.1052) (Figure 6E). Moreover, the upregulation of CD31 
MFI was also significantly lower in ∅Thy than in Thy (P = 0.0177) 
individuals, although the latter featured significantly higher ex 
vivo levels of CD31 MFI within the CD31+ subset (P = 0.0177) 
(Figure 6E). These findings suggest that naive CD4 T-cells from 
∅Thy patients lost the ability to respond to IL-7, possibly through 
the PI3K pathway, in agreement with their impaired prolifera-
tion. Conversely, they preserved the ability to upregulate Bcl-2 
in response to IL-7, which we have shown previously that is not 
PI3K-dependent (14, 28).
Altogether, these data showed that the ability of naive CD4 
T-cells to proliferate and upregulate CD31 in response to IL-7 
was impaired in individuals completely lacking thymic activity.
DiscUssiOn
We investigated here mechanisms of peripheral naive CD4 
T-cell homeostasis in adults with different degrees of thymus 
impairment since early infancy. We found that the size of the 
CD31− compartment was similar in healthy and thymectomized 
subjects, supporting the existence of thymus-independent home-
ostasis, possibly driven by self-peptide/MHC. On the other hand, 
proliferation mediated by IL-7, the main homeostatic cytokine, 
was severely impaired in the absence of thymopoiesis.
Thymectomy performed during corrective cardiac surgery in 
infancy is widely recognized as a powerful model to investigate 
the thymus contribution to naive T-cell maintenance beyond 
the establishment of the T-cell compartment. Nevertheless, a 
wide heterogeneity of findings has been reported (22–26, 32, 
44–47). Our study focused on adults thymectomized during 
infancy/early childhood within a relatively narrow age range, 
which were grouped according to absence (∅Thy) or presence 
(Thy) of thymopoiesis based on circulating sjTRECs/μl (5). Our 
molecular strategy to stringently rule out the existence of thymic 
output in thymectomized patients overcomes the limitations of 
other approaches based solely on surgical reports (21, 23, 32, 
44–46) and/or thoracic imaging (21, 32, 45, 48), which may have 
neglected thymic regeneration or ectopic thymus (49).
Of note, after the exclusion of the thymectomized patients 
lacking thymic activity, we found that both size and diversity of 
the naive CD4 T-cell compartment were preserved to a median 
of 21 years post-thymectomy. This likely occurred through both 
peripheral mechanisms and thymus regeneration, as supported 
by our finding of sj/βTREC ratios in Thy patients within the 
10
Silva et al. Naive CD4 Homeostasis upon Thymectomy
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 20
range of healthy age-matched controls. These data strengthen the 
recommendation to avoid complete thymectomy during cardiac 
surgery (44, 50), which is particularly relevant after the first year 
of life given the observed association between younger age at 
thymectomy and thymic recovery (24, 32).
The thymus provides a unique environment to generate a 
diverse TCR repertoire (51). This process that involves genomic 
recombination and gene editing at the individual cell level (52) 
imposes major challenges to the quantification of TCR diversity, 
particularly when sample availability is limited (52–57), leading 
us to opt for a standard approach using spectratyping. To our 
knowledge, there is only one study assessing the diversity of 
purified naive CD4 T-cells from three thymectomized children/
adolescents that reported conservation of the spectratyping 
profiles (25). We showed here that the diversity of the TCR rep-
ertoire within the naive CD4 T-cell compartment was preserved 
in thymectomized individuals with some degree of remaining 
thymic activity and significantly contracted in patients com-
pletely lacking thymopoiesis. Although ØThy featured no major 
infections or autoimmunity, this profile of premature immune 
senescence (21, 22, 46, 58) is likely to have clinical implications 
not yet evaluated, since successful corrective cardiac surgery in 
young children only became a routine practice three decades ago, 
precluding extended follow-up studies (45, 59).
Of note, patients lacking thymic activity featured no major 
change of the transcript levels of genes involved in cell quies-
cence and survival of naive CD4 T-cells, except for the significant 
increase in DUSP6. This phosphatase enhances the TCR activation 
threshold by decreasing ERK phosphorylation (39). However, 
no significant change was observed in the activation of purified 
naive CD4 T-cells, suggesting that this pathway does not limit 
their differentiation into the memory–effector pool in completely 
thymectomized patients. Accordingly, they featured an increase 
in cycling cells within the CD31− subset that is thought to mainly 
proliferate in response to TCR stimulation by low-affinity self-
peptide/MHC (2, 18).
We showed here that the maintenance of the CD31− subset 
is independent of thymic output, and that robust peripheral 
mechanisms ensure the homeostasis of this population. This is in 
agreement with the CD31− preservation that others have reported 
during age-associated thymic involution (12, 40). Our study 
revealed that, even in healthy young adults, the levels of the pro-
survival molecule Bcl-2 were significantly higher in CD31− than 
in CD31+ naive CD4 T-cells, emphasizing the contribution of 
anti-apoptotic pathways for the homeostasis of the CD31− subset 
(60).
IL-7 is known to play a crucial role in naive CD4 T-cell 
homeostasis, not only by enhancing thymopoiesis (61, 62) but 
also through the peripheral induction of survival and prolifera-
tion (14, 28, 56, 63). We show here that there is no reduction of 
IL-7Rα expression within naive CD4 T-cells from thymectomized 
individuals, and others have shown that IL-7Rα proximal signal-
ing, as assessed by STAT5 phosphorylation, were preserved (20). 
Our data support the notion that in the absence of thymopoiesis, 
there is mainly an impairment in the peripheral responses to 
IL-7 that are PI3K-dependent, namely, proliferation and CD31 
upregulation, whereas Bcl-2 induction, which does not rely on 
this pathway, is relatively preserved. We have previously reported 
preservation of naive regulatory T-cells in the same ØThy cohort, 
despite the marked contraction of conventional naive CD4 T-cells 
(28). In the current study, we further analyzed the expression of 
the regulatory marker FoxP3 within cycling naive CD4 T-cells, 
and found that in contrast to the conventional cells, the FoxP3+ 
featured significant proliferation rates upon culture with IL-7 
(median fold change of Ki-67+ cells as compared to ex vivo levels: 
3.41 for FoxP3+ versus 1.32 for Foxp3−, P = 0.0248, n = 5). These 
findings point to a defect of conventional naive CD4 T-cells. The 
comparison of the two naive CD4 T-cell subsets is therefore a 
promising strategy to clarify the mechanisms underlying the 
defective IL-7 response in complete thymectomized individuals. 
These data will foster our understanding of IL-7 signaling in 
human naive CD4 T-cells and possibly identify druggable targets.
Functional heterogeneity within naive CD4 T-cells may result 
from the maturation process that RTEs undergo in the periphery, 
which may vary throughout life (64–66). It is expectable that cells 
with privileged response to IL-7 are more abundant in the first 
years of life, when accelerated growth and constant exposure to 
new antigens demand for peripheral expansion to ensure con-
tinuous replenishment of the naive compartment. IL-7-induced 
proliferation is known to be higher in mature single-positive 
thymocytes than peripheral T-cells (28, 66) and in cord blood 
than adult naive CD4 T-cells (14). Moreover, it is plausible that 
in elderly, an impaired ability of circulating naive CD4 T-cells 
to proliferate in response to IL-7 contributes to their decline, in 
parallel with thymic involution (40). In this context, the low-level 
homeostatic proliferation of naive CD4 T-cells will progressively 
rely on self-peptide MHC interactions, which in addition to con-
strain the repertoire may promote aging-associated autoreactivity.
Our data suggest a scenario where proliferative responses to 
IL-7 would be favored in a narrow window of time upon thymic 
egress, which has important implications to the therapeutic use 
of IL-7 in clinical settings known to be associated with thymic 
injury, namely, HIV/AIDS (67, 68) and chemotherapy (69, 70). 
Therefore, the requirement for ongoing thymopoiesis questions 
the suggested benefit of IL-7 therapy in the recovery of lympho-
penia in thymectomized individuals (21).
In complete thymectomized individuals, the homeostatic 
proliferation of naive CD4 T-cells is likely to be mostly related 
to TCR stimulation by low-affinity self-peptide/MHC in both 
CD31− and CD31+ subsets, which likely contributes to further 
constrain their TCR repertoire.
In conclusion, our investigation of the interplay of thymic 
output and peripheral mechanisms to the maintenance of the 
naive CD4 T-cell compartment uncovered the need for contin-
ued thymic activity to the IL-7-driven peripheral proliferation of 
naive CD4 T-cells. These findings are of particular relevance for 
lymphopenic clinical settings and aging, demanding the appraisal 
of thymus targeting strategies in order to maximize the peripheral 
effect of IL-7.
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